Clinical Trial Update: Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 1/2 study evaluating AR-14034 for Neovascular Age-Related Macular Degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• AR-14034

Snippet

Sponsor: Alcon Research | Conditions: Neovascular Age-related Macular Degeneration (nAMD) | Phase 1, Phase 2 | Status: RECRUITING